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Abstract 19 
The health benefits of garlic have been proven by epidemiological and experimental studies. 20 
Diallyl disulphide (DADS), the major organosulfur compound found in garlic oil, is known to 21 
lower the incidence of breast cancer both in vitro and in vivo. The studies reported here 22 
demonstrate that DADS induces apoptosis in the MCF-7 breast-cancer cell line through 23 
interfering with cell-cycle growth phases in a way that increases the sub-G0 population and 24 
substantially halts DNA synthesis. DADS also induces phosphatidylserine (PS) translocation 25 
from the inner to the outer leaflet of the plasma membrane and activates caspase-3. Further 26 
studies revealed that DADS modulates the cellular levels of Bax, Bcl-2, Bcl-xL and Bcl-w in 27 
a dose-dependent manner, suggesting the involvement of Bcl-2 family proteins in DADS 28 
induced apoptosis. Histone deacetylation inhibitors (HDACi) are known to suppress cancer 29 
growth and induce apoptosis in cancer cells. Here it is shown that DADS has HDACi 30 
properties in MCF-7 cells as it lowers the removal of an acetyl group from an acetylated 31 
substrate and induces histone-4 (H4) hyper-acetylation. The data thus indicate that the 32 
HDACi properties of DADS may be responsible for the induction of apoptosis in breast 33 
cancer cells. 34 
Keywords  35 
Breast cancer, Diallyl disulphide, Apoptosis, Histone deacetylation inhibitor.  36 
37 
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Introduction 38 
Worldwide, breast cancer comprises 22.9% of all non-melanoma skin cancers and 13.7% of 39 
cancer deaths in women (1).  Some of the primary risk factors for female breast cancer 40 
include age (2), lack of childbearing or breastfeeding (3), high hormone levels (e.g. estrogen) 41 
(4) and ethnicity (5). However, diet is another important factor that contributes to the 42 
development of breast cancer (6-8). The impact of diet on the incidence of breast cancer is 43 
indicated by geographic differences in the occurrence of the disease (9), and by the many 44 
dietary components experimentally proven to act as anti-breast cancer agents. One such 45 
dietary factors is diallyl disulphide (DADS), which is a major (~60%) organosulfur 46 
compound found in garlic oil (10). DADS inhibits the growth of breast cancer cell lines 47 
(MDA-MB-231, KPL-1, MKL-F and MCF-7) (11) and reduces the incidence of N-methyl-N-48 
nitrosourea (MNU) and 2-amino-1-methyl-6-phenylimidazo-4-5-b-pyridine (PhIP)-induced 49 
mammary tumours (12, 13). The anti-cancerous effect of DADS is often attributed to its 50 
ability to induce apoptosis in cancer cells via cell-cycle arrest and modulation of the activity 51 
of Bcl-2 family proteins (14-16). 52 
The difference between normal and cancerous cells is that the later lack the ability to die. In 53 
normal tissue, a balance between cell proliferation and cell death must be maintained, 54 
otherwise cells display uncontrolled growth and thereby cancer arises (17). Cellular apoptosis 55 
or programmed cell death is the key process in maintaining this balance. Apoptosis naturally 56 
occurs in mammalian tissues and is regulated by a cascade of cellular proteins, such as pro- 57 
and anti-apoptotic molecules. Prominent among such factors are the Bcl-2 family proteins 58 
which act as signalling molecules in cellular apoptosis and survival pathways.  Bcl-2 family 59 
proteins include both pro-apoptotic (Bax, Bak, Bok, Bad, Bid, Bim and Bmf) and anti-60 
apoptotic members (Bcl-2, Bcl-xL, Bcl-w, Mcl-1 and Bfl-1/A1) (18, 19). Such pro-apoptotic 61 
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proteins function by promoting mitochondrial permeability, resulting in the release of 62 
apoptogenic factors (e.g. cytochrome c and apoptosis inducing factor [AIF]) from the 63 
mitochondrial inter-membrane space into the cytosol (20). The presence of such factors in the 64 
cytosolic compartment induces the activation of protease activators (caspases) that ultimately 65 
lead to apoptosis. Either increasing levels of pro-apoptotic Bcl-2 proteins or decreasing levels 66 
of anti-apoptotic Bcl-2 proteins (or a combination of both) can result in activation of the 67 
apoptotic machinery, thereby initiating apoptotic cell death. In this context, DADS up-68 
regulates pro-apoptotic Bcl-2 proteins in many types of cancerous cells. For example, DADS-69 
induces Bax expression and triggers the apoptotic mitochondrial pathway in MCF-7 human 70 
breast cancer cells (14), and is known to induce apoptosis through down-regulation of anti-71 
apoptotic Bcl-2 in A549 human lung adenocarcinoma cells (21). DADS also caused down-72 
regulation of the anti-apoptotic proteins Bcl-2 and Bcl-xL in a human colon cancer cell line 73 
(COLO 205), whereas it induced up-regulation of the pro-apoptotic Bak and Bax proteins 74 
(22). Furthermore, DADS treatment of a human prostate cancer cell line (PC-3) resulted in 75 
increased cellular levels of pro-apoptotic BAX and BAD, but decreased Bcl-2 levels (23).  In 76 
a similar study by Arunkumar et al. (2007), the apoptotic impact of DADS in PC-3 cells were 77 
accompanied by histone (H3 and H4) hyper acetylation (24).   78 
Aberrant gene transcription is common in malignant cells, resulting in activation of some 79 
genes and silencing of others (25, 26).  Such changes in transcriptional status are often 80 
correlated with alterations in histone acetylation with hyper-acetylation mediating activation 81 
whilst de-acetylation promotes gene silencing (27, 28). Histone acetylation controls 82 
transcription by facilitating or restraining the recruitment of transcription factors on to 83 
associated promoter (29, 30). Histone acetylation has received considerable interest of late 84 
because of its link to the pathogenesis of cancer.  The progression of carcinogenesis involves 85 
the transcriptional activation of ‘inappropriate’ genes (e.g. oncogenes, RAS, WNT, MYC, 86 
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ERK, TRK and Bcr-Abl) at the expense of tumour suppressor genes (e.g. TP53, CDKN1B, 87 
HNPCC, MEN1, APC, CD95, ST5, ST7, ST14 and BRCA) and pro-apoptotic genes (e.g. 88 
pro-apoptotic Bcl-2 proteins) (31-35). Since aberrant transcription of Bcl-2 family genes is 89 
often observed in breast cancer cells (36, 37), this raises the possibility that the modulation of 90 
expression of such genes by DADS is mediated by DADS-induced histone deacetylation 91 
inhibition (HDACi).  92 
This possibility raised above is addressed here through the investigation of the effect of 93 
DADS on the acetylation status of histones in the breast-cancer cell line, MCF-7. The data 94 
confirm that DADS strongly induces apoptosis in MCF-7 cells, which is apparently caspase 95 
dependent. DADS also enhances histone hyper-acetylation in MCF-7 cells, through its 96 
HDACi activity, and promotes pro-apoptotic Bax but depresses anti-apoptotic Bcl-2, Bcl-xL 97 
and Bcl-w.  Thus, the anti-cancerous activity of DADS could arise from its HDACi effect. 98 
Materials and Methods  99 
Cell line and treatment 100 
The human mammary gland adenocarcinoma cell line (MCF-7) (38) was kindly provided by 101 
Professor A El-Tayeb (Assiut University) and cells were used following 43–51 passages. 102 
Cells were cultured in Dulbecco’s modified Eagles’s minimum essential medium 103 
(CAMBREX) supplemented with 10% heat-inactivated (60 °C, 30 min) fetal bovine serum 104 
(FBS, CAMBREX) and antibiotics (100 U/ml penicillin, 100 µg/ml streptomycin), in six-well 105 
tissue culture plates in a concentration of 10
5
 cells/ml at 37 ˚C in a 5% CO2/95% humidified 106 
atmosphere. Culturing media were supplemented with DADS (Sigma, purity ≤ 80%) 107 
dissolved in dimethylsulfoxide [(DMSO), Aldrich, purity ≤ 95.5%)] in final concentrations of 108 
1, 10 or 100 µM DADS. The DMSO final concentration did not exceed 0.1% in all treatments 109 
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including control cultures. Trichostatin A (TSA), at 1 µM final concentration, was used to 110 
inhibit histone deacetylase activities in positive control samples (39) 111 
Cell cycle analysis 112 
MCF-7 cells, treated and control, were harvested by trypsinization. The cells were washed 113 
with phosphate buffered saline (PBS). Cells were then fixed by pipetting 1 ml of cell 114 
suspension (approximately 10
6
 cells/ml) was on to 4 ml of absolute ethanol at -20 °C in a 115 
Falcon tube while vortexing at top speed. Fixed cells were re-hydrated in 5 ml PBS for 15 116 
min at room temperature (RT). Finally, 3 mM propidium iodide (PI) in staining buffer (100 117 
mM Tris; pH 7.4, 150 mM NaCl, 1 mM CaCl2, 0.5 mM MgCl2, 0.1% NP-40) was added and 118 
mixed by gentle pipetting. Pancreatic RNAase (50 µl of 10 µg/ml stock; Sigma) was added 119 
and the cells were incubated for 2 h at 4 °C. Cell cycle analysis was performed using a 120 
FACScan Flow Cytometer (Becton Dickson) according to the manufacturer’s protocol. 121 
Annexin V/PI test 122 
MCF-7 cells were tested for apoptosis induction by DADS using Annexin V-FITC/PI double 123 
staining. Briefly, approximately 10
6
 cells  were washed in cold PBS followed by two washes 124 
in binding buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2, 5 mM KCl, 1 mM MgCl2, 125 
pH 7.4). Cells were then re-suspended in 100 µl Annexin V-FITC (4 µg/ml in binding buffer) 126 
and incubated on ice for 10 min. An additional 400 ml of binding buffer, containing PI 127 
(2 µg/ml), were added and the cellular suspension was incubated on ice for a further 15 min. 128 
Cells thus treated were then analysed by flow cytometry.   129 
Caspase-3 activation 130 
MCF-7 cells were seeded in 96-well plates at a density of 10
5
 cells/well. Plates were then 131 
incubated overnight at 37˚C in a ‘5% CO2/95% humidity’ atmosphere. DADS was added at 132 
final concentrations of 1, 10 and 100 µM and cells were incubated for an additional 24 h. For 133 
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positive controls, cells were treated with staurosporine (3 µg/ml) for 4 h (40) prior to 134 
performing the assay. Caspase-3 activation upon DADS treatment was measured using the 135 
Caspase-3 Fluorescence Assay Kit (Cayman chemicals) according to the manufacturer’s 136 
instructions. In order to test assay specificity, negative control samples were prepared by 137 
adding 10 µl/well of caspase-3 inhibitor solution (provided with the kit). The plates were read 138 
on a FLUOstar OPTIMA fluorescent plate reader at 485 nm excitation and 535 nm emission 139 
wavelengths. 140 
Cellular lysate preparation and Western blot 141 
Cells were lysed with Radio-Immuno Precipitation Assay (RIPA) lysis buffer (50 mM Tris–142 
HCl, pH 8, 150 mM NaCl, 0.02% sodium azide, 0.1% SDS, 100 µg/ml PMSF 143 
[phenylmethylsulphonyl fluoride], 1 µg/ml aprotinin, 1% NP-40) for 30 min on ice. The 144 
cellular lysate was then centrifuged at 12,000×g for 2 min at 4 °C. The supernatant was then 145 
transferred to a fresh Eppendorf tube, and total protein concentrations were determined using 146 
the BioRad protein assay (41). Cellular lysates were then denatured with an equal volume of 147 
loading buffer (0.125 M Tris–HCl, 4% SDS, 20% v/v glycerol, 0.2 M dithiothreitol, 0.02% 148 
bromophenol blue, pH 6.8) at 100 °C for 10 min. Protein samples (50 µg) were then 149 
immediately subjected to SDS-PAGE (BioRad Mini Protein II Electrophoresis gel) and trans-150 
blotted onto a nitrocellulose membrane (Amersham). The membranes were blocked in 5% 151 
non-fat dry milk in TBS (20 mM Tris–HCl, 500 mM NaCl, pH 7.5) overnight at 4 °C. The 152 
membranes were immuno-stained for pro-apoptotic (Bax, Bak and Bid) and anti-apoptotic 153 
Bcl-2 proteins (Bcl-2 and Bcl-xL [rabbit polyclonal, Abcam] and Bcl-w [Cell Signaling 154 
Technology®]). β-Actin primary antibody (mouse monoclonal, Abcam) was used as a 155 
loading control. Immuno-detected band visualisation was carried out using the 156 
chemiluminescent alkaline phosphatase substrate (Immobilom™ Western).  157 
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Histone extraction and electrophoresis 158 
Histone extraction was performed as previously published (42). Approximately 10
7
 cells, 159 
treated and control, were resuspended in 1 ml nuclear extraction buffer (60 mM KCI, 15 mM 160 
NaCl, 3 mM MgCl2, 15 mM piperazine- N/N' bis [2 ethanesulfonic acid]; pH 6.5, 0.1% NP-161 
40, 0.5 mM phenyl methyl sulfonyl fluoride, 1 mM tetrathionate) and kept on ice for 20 min, 162 
and then centrifuged at 1300 xg and 4 °C for 10 min.  The resulting nuclear pellet was 163 
suspended in H2SO4 (0.2 M final concentration) for 2 h and centrifuged at 10,000 xg and 4 °C 164 
for 10 min. The supernatants containing the histones were removed, and dissolved histones 165 
were precipitated with absolute alcohol at -20 °C. The precipitant was suspended in water and 166 
quantified by Bio-Rad protein assay (41). A 1 ml volume of sample buffer was prepared by 167 
mixing 7.7 mg dithiothreitol (DTT), 900 µl of 8 M urea, 50 µl phenolphthalein [1% w/v in 168 
95% ethanol] and 50 µl of 30% NH4OH. The sample buffer was then added to the dissolved 169 
histones in a 1:1 v/v ratio, and kept for 5 min at RT. Samples were then acidified by adding 170 
5 µl of glacial acetic acid. Histones were electrophoresed in a Triton-Aced-Urea (TAU) gel as 171 
described previously (43).  172 
Nuclear extract preparation and DADS-HDACi activity analysis 173 
Nuclear extracts were prepared as described before (44). Approximately 10
7
 cells were lysed 174 
in 1 ml of ice cold lysis buffer (10 mM Tris-HCl, 10 mM NaCl, 15 mM MgCl2, 250 mM 175 
sucrose, 0.1 mM ethylene glycol bis-[beta-aminoethylether] N,N,N[1]-tetraacetic acid 176 
[EGTA], 0.5% NP-40; pH 7.5), and kept on ice for 15 min. The suspension was then 177 
carefully pipetted over a 4 ml layer of sucrose buffer (30% sucrose, 10 mM Tris-HCl, 10 mM 178 
NaCl, 3 mM MgCl2, pH 7.5), and centrifuged at 1300 xg and 4 °C for 10 min. The pellet was 179 
resuspended in Tris-HCl buffer (10 mM Tris-HCl, 10 mM NaCl, pH 7.5) and centrifuged at 180 
1300 xg, 4 °C for 10 min. The pellet (nuclear fraction) was re-suspended in extraction buffer 181 
(50 mM HEPES, 420 mM NaCl, 0.5 mM EDTA, 0.1 mM EGTA, 10% glycerol, pH 7.5) and 182 
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ultrasonicated for 30 s and kept on ice for 30 min. The mixture was then centrifuged at 183 
10,000 xg and 4 °C for 10 min. The supernatant (nuclear extract) was collected and kept at -184 
80 °C for HDAC activity analysis. Different concentrations of DADS were tested for HDACi 185 
activity, using the fluor de lys
TM
 fluorescent assay system (Drug discovery kit-AK-500; 186 
BIOMOL) according to the manufacture instructions. The kit includes deacetylases inhibitor 187 
(Trichostatin A [TSA]) for use as positive control. The samples were quantified on a 188 
FLUOstar OPTIMA fluorescent plate reader at 360 nm excitation and 460 nm emission 189 
wavelengths. 190 
Statistical Analysis 191 
All data were obtained from three independent experiments, and all results are expressed as 192 
mean±SE. We employed the two-tailed (or paired) Student’s t-test, using Microsoft Excel, to 193 
determine significant differences. In all analysis, differences with probability values ≤ 0.05 194 
were considered significant. 195 
 196 
 197 
Results 198 
DADS induce cell-cycle arrest and apoptosis in MCF-7 cells 199 
Cell-cycle analysis of MCF-7 cells treated with 0-100 µM DADS showed that such treatment 200 
causes changes in the occupation of the various stages of the cell cycle (Fig. 1).  DADS 201 
stimulated a concentration-dependent increase in the sub-G0 population (representing 202 
apoptotic bodies and/or cells with fragmented DNA) combined with a corresponding 203 
decrease in the S-phase population.  Thus, 100 µM DADS induces a 56.9% (p ≤ 0.05) 204 
reduction in the proportion of cells engaging in DNA synthesis (the S-phase population) 205 
coupled with more than a tenfold increase (from 3.16 to 31.1%; p ≤ 0.05) in the number of 206 
apoptotic, sub-G0 cells (Fig. 1).  In contrast, the G0/G1 and G2/M populations were little 207 
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affected by DADS (Fig. 1). The DADS induction of apoptosis was confirmed by Annexin 208 
V/PI double staining which detects both early and late apoptotic cells (AV and PI stained 209 
cells, respectively). Annexin V binds to phosphatidylserine (PS) translocated from the inner 210 
leaflet of the plasma membrane (considered a hallmark of early apoptosis (45)). DADS 211 
increased the number of early apoptotic cells from 11.0% (in untreated cells) to 18.2 (p ≤ 212 
0.05), 23.2 (p ≤ 0.05) and 34.8% (p ≤ 0.05) in 1, 10 and 100 µM treated cells, respectively. 213 
Late apoptotic cells numbers were also increased in a dose-dependent manner from 7.17% in 214 
untreated cells to 11.2 (p ≤ 0.05), 16.3 (p ≤ 0.05) and 24.9% (p ≤ 0.05) in 1, 10 and 100 µM 215 
DADS treated cells (Fig. 2).  Thus, the double-staining analysis indicates that 100 µM DADS 216 
increased total apoptotic cell numbers by more than threefold from 18.2 to 59.7% (p ≤ 0.05) 217 
(Fig. 2), a result which closely matches that obtained by single labeling (Fig. 1). 218 
DADS increases caspase-3 activity in MCF-7 cells 219 
In order to determine whether activation of caspase-3 might be involved in the observed 220 
DADS-induced apoptosis of MCF-7 cells, such cells were tested for caspase-3 activity 221 
following DADS treatment, by fluorescence assay. The results show that caspase-3 activity 222 
increased by 80.8% ± 24.9 and 270% ± 13.6 in cells treated with 10 and 100 µM DADS, 223 
respectively, compared to untreated cells (Fig. 3). Indeed, the caspase-3 induction achieved 224 
by the highest dose of DADS (370%) was close to that obtained by staurosporine (500%) (the 225 
positive control).  However, low concentrations (1 µM) of DADS had no significant impact 226 
on caspase-3 activation. ‘Caspase-3 inhibitor’ eliminated the effects of DADS on caspase-3 227 
activity indicating that the increases in activity observed in the absence of inhibitor were 228 
indeed caspase-3 specific (Fig. 3).  These results show that DADS elicits a dose-dependent 229 
stimulation of caspase-3 activity in MCF-7 cells (Fig. 3) which suggests that caspase-3 230 
activation is a component of the DADS-dependent induction of apoptosis in MCF-7 cells. 231 
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DADS modulates the expression of Bcl-2 proteins in MCF-7 cells 232 
In order to further confirm that DADS induces apoptosis in breast cancer cells and to 233 
determine the likely regulatory pathway involved, Western blotting was used to examine the 234 
effect of DADS on the levels of three pro-apoptotic proteins (Bax, Bak and Bid) in MCF-7 235 
cells. The results show that cellular levels of Bax were raised by 23.0% ± 8.15 and 32.4% ± 236 
7.83, respectively, by treatment with 10 and 100 µM DADS, although levels were not notably 237 
affected by DADS at 1 µM (Fig. 4). In contrast, DADS failed to significantly increase the 238 
levels of either Bak or Bid in MCF-7 cells (Fig. 4). However, all three of the anti-apoptotic 239 
Bcl-2 proteins examined here were reduced by DADS treatment: 10 and 100 µM DADS 240 
decreased Bcl-2 cellular levels by 42.2% ± 9.13 and 64.4% ± 9.7; Bcl-xL cellular levels were 241 
decreased by 33.3% ± 8.7 and 57.7% ± 7.7; and Bcl-w cellular levels were decreased by 242 
38.1% ± 8.4 and 68.6% ± 7.4, respectively (Fig. 4). Thus, DADS at 10-100 µM raises the 243 
MCF-7 cellular levels of at least one pro-apoptotic Bcl-2 family protein (Bax) and decreases 244 
those of at least three anti-apoptotic Bcl-2 proteins (Bcl-2, Bcl-xL and Bcl-w).  These effects 245 
are again fully consistent with the DADS-induced apoptosis reported above, and roles for 246 
Bcl-2 proteins in modulating DADS-stimulated apoptosis in MCF-7 cells. 247 
 248 
DADS induces H4 acetylation and inhibits the deacetylation activity of MCF-7 nuclear 249 
extract 250 
The above studies show that the apoptosis effect generated by DADS in MCF-7 cells 251 
correlates with appropriate changes in the levels Bcl-2 family proteins.  Previous work 252 
suggests that such changes in protein levels may arise from alterations in expression caused 253 
by modifications of histone acetylation status (46, 47).  To determine whether the effects of 254 
DADS might arise through alterations in histone acetylation, global changes in overall 255 
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histone acetylation levels were assayed using TAU gel electrophoresis (Fig.5 I). This analysis 256 
showed that histone 4 is primarily in the unacetylated and mono-acetylated forms in untreated 257 
MCF-7 cells.  However, following treatment with 1 µM DADS, the di-acetylated form of 258 
histone 4 became apparent as a minor species. As the DADS concentrations were raised more 259 
so, the acetylation profiles were further altered as tri- and tetra-acetylated histone 4 became 260 
increasingly apparent (Fig. 5I).  Thus, DADS treatment raises the histone-4 acetylation status 261 
of MCF-7 nuclear DNA. 262 
To determine whether the increased histone acetylation levels are caused by DADS-mediated 263 
inhibition of deacetylase activity, the effect of DADS on the ability of MCF-7 nuclear 264 
extracts to remove acetyl groups from an acetylated substrate was investigated (Fig.5 II).  The 265 
addition of DADS, at 10 and 100 µM, to MCF-7 nuclear extracts diminished deacetylation 266 
activities to 85.7% ± 17.6 and 64.2% ± 12.9 of that of controls, although 1 µM DADS had no 267 
significant effect.  TSA, a potent deacetylases inhibitor (39), reduced deacetylation to 24.77% 268 
± 7.6 of that of the control, showing that the assay was effective in reporting deacetylation 269 
inhibition. The results therefore suggest that the DADS-induced increase in acetylation of 270 
histone 4 is caused by the ability of DADS to act as a direct HDAC inibitor.  271 
Discussion 272 
The health benefits and medicinal properties of garlic have long been known. Records dating 273 
back to 1550 BC describe garlic as a "wonder drug" for a variety of diseases (48). 274 
Epidemiological studies report that high consumption of garlic decreases the risk of breast 275 
cancer (49, 50).  This effect has been attributed to DADS, which is present in garlic cloves at 276 
~140 mM as the major organosulfur compound of garlic oil (51), since it inhibits the growth 277 
of breast cancer cells in vitro through induction of apoptosis (14, 16).  The effects of DADS 278 
are not confined to cancerous cells; it has been shown that DADS suppresses hepatic P450 279 
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2E1 protein expression and N-nitrosodimethylamine demethylase activity (52, 53). It is 280 
suggested that this may affect the metabolic activation of procarcinogens and the clearance 281 
rate of toxic metabolites (54).  282 
It should be stressed that human studies on garlic consumption and cancer risk provide 283 
limited evidence of any relationship between garlic intake and protection against cancer (55-284 
58).  However, the value of such human studies is often limited by variability in the garlic 285 
preparations taken and uncertainty concerning the amounts of garlic consumed (58), and it is 286 
suggested that further human trials are required in order to establish whether dietary garlic 287 
exhibits any anti-cancerous effects (59). Important factors affecting DADS availability in 288 
food include alkalinity and processing, which highlights the need to consider various aspects 289 
of diet, as well as the composition of the garlic, when assessing any health benefit of garlic in 290 
clinical trials (60-63). Although the direct exposure of human breast cancer cells to DADS 291 
(as performed here) fails to replicate the complexity of the whole human system, such studies 292 
have the advantage of avoiding the problems raised above that are associated with diet 293 
composition effects. 294 
The studies reported here confirm that DADS is able to induce apoptosis in the breast cancer 295 
cell line, MCF-7, by interfering with the cell cycle. DADS increased the sub-G0, apoptotic 296 
population in a dose-dependent manner and at the same time decreased the occupancy of the 297 
S phase of the cycle, indicating an inhibition of DNA synthesis had occurred. These findings 298 
are consistent with those reported previously (11, 16, 64-67) where the growth inhibitory 299 
properties of DADS were also attributed to its induction of apoptosis and reduction in DNA 300 
synthesis in KPL-1, MCF-7, COLO 205, HCT-116 and B16F-10 cells. Examination of both 301 
early (e.g. PS translocation) and late (e.g. caspase-3 activation) molecular events 302 
characteristic of apoptosis confirmed the ability of DADS, at physiologically relevant 303 
concentration (10–100 µM), to induce apoptosis in MCF-7 cells.  304 
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Bcl-2 family proteins play an important role in the progression of apoptosis through 305 
controlling the release of apoptogenic factors, e.g. cytochrome c and ‘apoptosis-inducing 306 
factor’ (AIF), from the mitochondrial inter-membrane space into the cytosol (20, 68).  307 
Released cytochrome c binds to cytosolic Apaf-1 to form the ‘apoptosome’ in a reaction that 308 
eventually leads to the autoactivation of pro-caspase-9 (69) which in turn activates the 309 
effector caspases (-3, -6 and -7) leading to apoptosis (70). Released AIF is translocated to the 310 
nucleus where it induces DNA fragmentation (71).  The balance between the levels of pro- 311 
and anti-apoptotic proteins within the cell is crucial in determining whether apoptosis 312 
progresses (72). The involvement of Bcl-2 family proteins in DADS-induced apoptosis in 313 
MCF-7 cells was suggested (Fig. 4) by the DADS-dependent increase of the cellular levels of 314 
pro-apoptotic Bax and concomitant decreases of anti-apoptotic Bcl-2, Bcl-xL and Bcl-w. The 315 
results therefore suggest the involvement of Bcl-2 family proteins in the progression of 316 
DADS-induced caspase-dependent apoptosis in MCF-7 cells. The results reported here are in 317 
accordance with previous work (14), where DADS was shown to cause caspase-dependent 318 
apoptosis in human breast cancer cells MCF-7 through the Bax-triggered mitochondrial 319 
pathway. The involvement of Bcl-2 family proteins in DADS-induced apoptosis was also 320 
shown in human lung adenocarcinoma A549 cells (21), where a decrease in the expression of 321 
Bcl-2 (but no change of Bax levels) was elicited by treatment with 200 µM DADS for 24 h.         322 
Interest in HDAC inhibitors has risen recently because of their anticancer potential; various 323 
HDACi have the ability to suppress cancer growth and induce apoptosis in vitro in cancer cell 324 
cultures and in vivo in tumor bearing animal models (73-76). In this study, it was shown that 325 
DADS has HDACi properties when presented at relatively low concentrations (10-100 µM) 326 
that are likely to be well within dietary concentrations ranges (51).  Low concentrations of 327 
DADS were found to inhibit the removal of the acetyl group from an acetylated substrate 328 
through reducing the HDAC enzymatic activity of MCF-7 nuclear extracts by up to 35.8%. 329 
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Furthermore, the appearance of di-, tri- and tetra-acetylated H4 in DADS-treated cells 330 
demonstrated the induction of histone hyper-acetylation by DADS. Induction of cellular 331 
changes characteristic of apoptosis, such as cell cycle arrest, cellular senescence, and 332 
activation of cell death in cancerous cells upon the treatment with a variety of HDAC 333 
inhibitors, has been confirmed in many studies, although the underlying mechanisms are not 334 
entirely clear (77-79). Such apoptotic changes were clearly seen here in DADS-exposed 335 
MCF-7 cells. Previous studies have shown that modulation of gene expression occurs upon 336 
alteration of the acetylation status of associated histones.  It is thought that histone hyper-337 
acetylation promotes localised chromatin de-condensation (80) which thereby facilitates 338 
binding of transcriptional factors at cognate promoters, leading to induction of gene 339 
expression. DADS is likely to operate similarly by inducing histone hyper-acetylation 340 
through its HDACi activity resulting in alterations in the expression of various apoptosis 341 
factors, such as the pro- and anti-apoptotic Bcl-2 family proteins as observed here. However, 342 
the precise mechanism by which Bcl-2 family protein expression is modulated and apoptosis 343 
is induced by DADS remains unclear. Similar effects were obtained when a renal tubular cell 344 
line (RPTC) was treated with a histone deacetylase inhibitor (suberoylanilide hydroxamic 345 
acid). This caused a decrease in Bcl-xL levels, while the expression levels of Bax and Bak 346 
remained relatively constant (81). It is unlikely that all of the expression changes observed 347 
here are a direct effect of histone acetylation status, since levels of Bcl-2, Bcl-xL and Bcl-w 348 
were decreased (rather than increased) by DADS. Thus, further work is required to decipher 349 
the precise manner in which DADS promotes apoptosis in MCF-7 breast cancer cells.  350 
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Abbreviations 356 
DADS  Diallyl disulphide 357 
DMSO  Dimethylsulfoxide 358 
FBS  Fetal bovine serum  359 
HDAC  Histone deacetylation 360 
HDACi Histone deacetylation inhibitor 361 
PBS  Phosphate buffered saline 362 
PI   Propidium iodide 363 
PS  phosphatidylserine  364 
RIPA  Radio-Immuno Precipitation Assay 365 
RT   Room temperature 366 
TSA   Trichostatin A  367 
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Figure 1: Cell-cycle analysis of  PI labeled MCF-7 cells following treatment with 1, 10 and 
100 µM DADS for 24 h. The results are reported as mean ± SE of three 
independent experiments. *, significance (p ≤ 0.05).     
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Figure 2: Estimation of the effect of DADS on the proportion of MCF-7 cells in late and 
early apoptotic states.  The analysis was performed by flow-cytometry of Annexin 
V/PI-labeled cells following DADS (1, 10 and 100 µM) treatment for 24 h. The 
results are reported as mean ± SE of three independent experiments. *, significant 
(p ≤ 0.05). 
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Figure 3: Fluorescence assay of caspase-3 activity in MCF-7 cells following DADS (1, 10 
and 100 µM) treatment for 24 h. The positive control consists of MCF-7 cells  
treated as above except for the inclusion of the caspase-3 inducer, staurosporine 
(3 µg/ml), for the final 4 h. Negative controls were also obtained as above except 
that the inducer was replaced by a caspase-3 inhibitor solution (10 µl; see 
Methods) which was present for the entire 24 h growth period. The results are 
reported as mean ± SE of three independent experiments. *, significant (p ≤ 0.05). 
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Figure 4: Western blot and densitometric analysis showing the effect of DADS on the levels 
of pro- and anti-apoptotic Bcl-2 proteins in MCF-7 cells. Cell cultures were treated 
with DADS for 24 h.  Loading control, β-actin detection. Densitometric analysis was 
performed using TotaLabTM software. The results are reported as mean ± SE of three 
independent experiments. *, significant (p ≤ 0.05). 
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Figure 5: Effect of DADS on histone acetylation in Mcf-7 cells. (I) DADS induction (24 h) 
of histone 4 hyper-acetylation in MCF-7 cells, assessed by TAU gel 
electrophoresis as in materials and methods. (II) DADS inhibition of histone 
deacetylation in MCF-7 nuclear extracts as determined using the Fluor de Lys 
substrate (Fluorimetric Assay/Drug Discovery Kit; BIOMOL); data is represented 
as arbitrary fluorescent units and measured as a percentage of the fluorescence 
signal obtained with no addition of DADS or TSA to the reaction mixture. The 
results are reported as mean ± SE of three independent experiments. *, significant 
(p ≤ 0.05). 
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